• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors for symptomatic intracranial hemorrhage after intravenous thrombolysis with acute ischemic stroke within 6 h in northern China: a multicenter, retrospective study.中国北方 6 小时内急性缺血性脑卒中静脉溶栓后症状性颅内出血的预测因素:一项多中心回顾性研究。
BMC Neurol. 2022 Jan 3;22(1):6. doi: 10.1186/s12883-021-02534-9.
2
Nomogram to Predict Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in Asian Population.亚洲人群急性缺血性脑卒中静脉溶栓后症状性颅内出血的预测列线图
Curr Neurovasc Res. 2021;18(5):543-551. doi: 10.2174/1567202619666211223150907.
3
Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.与急性卒中全身溶栓后症状性出血转化相关的实验室因素。
J Neurol Sci. 2021 Jan 15;420:117265. doi: 10.1016/j.jns.2020.117265. Epub 2020 Dec 9.
4
Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.症状性颅内出血与替奈普酶和阿替普酶治疗急性缺血性脑卒中:急性缺血性脑卒中常规替奈普酶与阿替普酶的比较效果(CERTAIN)协作组。
JAMA Neurol. 2023 Jul 1;80(7):732-738. doi: 10.1001/jamaneurol.2023.1449.
5
Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.中国患者静脉溶栓后症状性脑出血:预测模型的比较
J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1235-43. doi: 10.1016/j.jstrokecerebrovasdis.2015.01.026. Epub 2015 Apr 16.
6
Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.昼夜节律与急性缺血性脑卒中静脉溶栓后出血性转化风险的关系:系统评价。
CNS Neurol Disord Drug Targets. 2023;22(10):1493-1506. doi: 10.2174/1871527322666221004113752.
7
Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.静脉溶栓后与症状性颅内出血相关的肾功能障碍。
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104363. doi: 10.1016/j.jstrokecerebrovasdis.2019.104363. Epub 2019 Sep 6.
8
Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.重组组织型纤溶酶原激活剂溶栓治疗急性缺血性脑卒中后院内死亡率及症状性颅内出血的风险预测因素。
J Stroke Cerebrovasc Dis. 2014 Jan;23(1):7-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.004. Epub 2012 May 11.
9
Construction and validation of a nomogram model to predict symptomatic intracranial hemorrhage after intravenous thrombolysis in severe white matter lesions.构建并验证预测严重脑白质病变患者静脉溶栓后症状性颅内出血的列线图模型。
J Thromb Thrombolysis. 2023 Jul;56(1):111-120. doi: 10.1007/s11239-023-02828-4. Epub 2023 May 16.
10
Predictors of functional outcome after symptomatic intracranial hemorrhage complicating intravenous thrombolysis: results from the SITS-ISTR.症状性颅内出血合并静脉溶栓治疗后功能结局的预测因素:来自 SITS-ISTR 的结果。
Eur J Neurol. 2023 Oct;30(10):3161-3171. doi: 10.1111/ene.15968. Epub 2023 Jul 14.

引用本文的文献

1
A multi-center study on the predictors of different subtypes of hemorrhagic transformation of brain infarction after thrombolysis in atrial fibrillation patients presented with embolic stroke.一项关于心房颤动合并栓塞性卒中患者溶栓后脑梗死出血转化不同亚型预测因素的多中心研究。
Sci Rep. 2025 May 5;15(1):15655. doi: 10.1038/s41598-025-97968-3.
2
CILO-CLOP Trial: Cilostazol Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke: A Randomized Controlled Multicenter Trial.西洛他唑与氯吡格雷治疗急性中度及中重度缺血性卒中的随机对照多中心试验:CILO-CLOP试验
Neurol Ther. 2025 Jun;14(3):927-948. doi: 10.1007/s40120-025-00739-5. Epub 2025 Apr 12.
3
Effect of intravenous urokinase vs best medicine treatment on functional outcome for patients with acute minor stroke (TRUST): a randomized controlled trial.静脉注射尿激酶与最佳药物治疗对急性轻度中风患者功能结局的影响(TRUST):一项随机对照试验
BMC Med. 2025 Jan 6;23(1):6. doi: 10.1186/s12916-024-03820-2.
4
A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis.多中心试验:溶栓后不同亚型出血性梗死的预测因子。
Sci Rep. 2024 Nov 30;14(1):29822. doi: 10.1038/s41598-024-76189-0.
5
Analysis of Mortality in Intracerebral Hemorrhage Patients with Hyperacute Ischemic Stroke Treated Using Thrombolytic Therapy: A Nationwide Population-based Cohort Study in South Korea.使用溶栓疗法治疗的超急性缺血性卒中合并脑出血患者的死亡率分析:韩国一项基于全国人群的队列研究
J Pers Med. 2022 Jul 30;12(8):1260. doi: 10.3390/jpm12081260.
6
Application of Multimodal Magnetic Resonance Imaging in Green Channel of Acute and Hyperacute Ischemic Stroke.多模态磁共振成像在急性和超急性缺血性脑卒中绿色通道中的应用。
Contrast Media Mol Imaging. 2022 Jul 22;2022:2452282. doi: 10.1155/2022/2452282. eCollection 2022.

本文引用的文献

1
A Nomogram to Predict Symptomatic Intracranial Hemorrhage After Intravenous Thrombolysis in Chinese Patients.预测中国患者静脉溶栓后症状性颅内出血的列线图
Neuropsychiatr Dis Treat. 2021 Jul 6;17:2183-2190. doi: 10.2147/NDT.S320574. eCollection 2021.
2
Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.与急性卒中全身溶栓后症状性出血转化相关的实验室因素。
J Neurol Sci. 2021 Jan 15;420:117265. doi: 10.1016/j.jns.2020.117265. Epub 2020 Dec 9.
3
The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.中国与北美急性缺血性卒中溶栓后出血转化风险的比较研究
J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2381-2387. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.027. Epub 2018 May 31.
4
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.2018 急性缺血性脑卒中患者早期管理指南:美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2018 Mar;49(3):e46-e110. doi: 10.1161/STR.0000000000000158. Epub 2018 Jan 24.
5
The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke.中国卒中协会科学声明:急性缺血性脑卒中的静脉溶栓治疗。
Stroke Vasc Neurol. 2017 Jun 2;2(3):147-159. doi: 10.1136/svn-2017-000074. eCollection 2017 Sep.
6
Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke.中国急性缺血性脑卒中患者溶栓后症状性颅内出血的预测因素
PLoS One. 2017 Sep 18;12(9):e0184646. doi: 10.1371/journal.pone.0184646. eCollection 2017.
7
Predictors for Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Acute Ischemic Stroke.急性缺血性卒中血管内治疗后症状性颅内出血的预测因素
Stroke. 2017 May;48(5):1203-1209. doi: 10.1161/STROKEAHA.116.016368. Epub 2017 Apr 3.
8
Prognostic Parameters for Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in an Asian Population.亚洲人群急性缺血性卒中静脉溶栓后症状性颅内出血的预后参数
Curr Neurovasc Res. 2017;14(2):169-176. doi: 10.2174/1567202614666170327163905.
9
Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells.缺血性中风后的炎症反应:白细胞和神经胶质细胞的作用
Exp Neurobiol. 2016 Oct;25(5):241-251. doi: 10.5607/en.2016.25.5.241. Epub 2016 Oct 26.
10
Reduction of the systemic inflammatory induced by acute cerebral infarction through ultra-early thrombolytic therapy.通过超早期溶栓治疗减轻急性脑梗死所致的全身炎症反应。
Exp Ther Med. 2015 Oct;10(4):1493-1498. doi: 10.3892/etm.2015.2672. Epub 2015 Aug 6.

中国北方 6 小时内急性缺血性脑卒中静脉溶栓后症状性颅内出血的预测因素:一项多中心回顾性研究。

Predictors for symptomatic intracranial hemorrhage after intravenous thrombolysis with acute ischemic stroke within 6 h in northern China: a multicenter, retrospective study.

机构信息

Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Weiqi Road, Jinan, Shandong, 250021, PR China.

Department of Emergency, Linyi People's Hospital Affiliated to Shandong University, Lin yi, Shandong, China.

出版信息

BMC Neurol. 2022 Jan 3;22(1):6. doi: 10.1186/s12883-021-02534-9.

DOI:10.1186/s12883-021-02534-9
PMID:34980004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8722135/
Abstract

BACKGROUND AND PURPOSE

This study assessed the predictive factors for symptomatic intracranial hemorrhage (sICH) in patients with acute ischemic stroke (AIS) after receiving intravenous thrombolysis (IVT) within 6 h in northern China.

METHODS

We retrospectively analyzed ischemic stroke patients who were treated with IVT between November 2016 and December 2018 in 19 hospitals in Shandong Province, China. Potential predictors of sICH were investigated using univariate and multivariate analyses.

RESULTS

Of the 1293 enrolled patients (845 men, aged 62 ± 11 years), 33 (2.6%) developed sICH. The patients with sICH had increased coronary heart disease (36.4% vs. 13.7%, P = 0.001), more severe stroke (mean National Institutes of Health Stroke Scale [NIHSS] score on admission of 14 vs.7, P < 0.001), longer door-to-needle time [DNT] (66 min vs. 50 min, P < 0.001), higher blood glucose on admission, higher white blood cell counts (9000/mm vs. 7950/mm, P = 0.004) and higher neutrophils ratios (73.4% vs. 67.2%, P = 0.006) et al. According to the results of multivariate analysis, the frequency of sICH was independently associated with the NIHSS score (OR = 3.38; 95%CI [1.50-7.63]; P = 0.003), DNT (OR = 4.52; 95%CI [1.69-12.12]; P = 0.003), and white blood cell count (OR = 3.59; 95%CI [1.50-8.61]; P = 0.004). When these three predictive factors were aggregated, compared with participants without any factors, the multi-adjusted odds ratios (95% confidence intervals) of sICH for persons concurrently having one, two or three of these factors were 2.28 (0.25-20.74), 15.37 (1.96-120.90) and 29.05 (3.13-270.11), respectively (P for linear trend < 0.001), compared with participants without any factors.

CONCLUSION

NIHSS scores higher than 10 on admission, a DNT > 50 min, and a white blood cell count ≥9000/mm were independent risk factors for sICH in Chinese patients within 6 h after IVT for AIS.

摘要

背景与目的

本研究评估了在中国北方,在 6 小时内接受静脉溶栓(IVT)治疗的急性缺血性脑卒中(AIS)患者发生症状性颅内出血(sICH)的预测因素。

方法

我们回顾性分析了 2016 年 11 月至 2018 年 12 月在中国山东省 19 家医院接受 IVT 治疗的缺血性脑卒中患者。使用单变量和多变量分析来研究 sICH 的潜在预测因素。

结果

在纳入的 1293 例患者(845 例男性,年龄 62±11 岁)中,有 33 例(2.6%)发生了 sICH。sICH 患者的冠心病发生率更高(36.4% vs. 13.7%,P=0.001),卒中严重程度更严重(入院时平均国立卫生研究院卒中量表[NIHSS]评分 14 分 vs. 7 分,P<0.001),门到针时间更长[DNT](66 分钟 vs. 50 分钟,P<0.001),入院时血糖更高,白细胞计数更高(9000/mm vs. 7950/mm,P=0.004),中性粒细胞比例更高(73.4% vs. 67.2%,P=0.006)等。根据多变量分析的结果,sICH 的发生频率与 NIHSS 评分(比值比[OR]:3.38;95%置信区间[CI]:1.50-7.63;P=0.003)、DNT(OR:4.52;95%CI:1.69-12.12;P=0.003)和白细胞计数(OR:3.59;95%CI:1.50-8.61;P=0.004)独立相关。当将这三个预测因素汇总时,与无任何因素的参与者相比,同时存在一个、两个或三个这些因素的 sICH 患者的多调整比值比(95%置信区间)分别为 2.28(0.25-20.74)、15.37(1.96-120.90)和 29.05(3.13-270.11)(P 值<0.001),与无任何因素的参与者相比。

结论

入院时 NIHSS 评分>10 分、DNT>50 分钟和白细胞计数≥9000/mm 是中国患者在 AIS 后 6 小时内接受 IVT 治疗后发生 sICH 的独立危险因素。